NVTA
Invitae is a genetics company providing comprehensive DNA-based testing and interpretation to support personalized health care. In collaboration with Labcorp, it aims to make genetic data accessible within medical practices to inform patient care across oncology, women’s health, pediatrics and rare diseases. The company emphasizes counseling support, broad test catalog, and nationwide access to enable clinicians and patients to act on genetic insights. Headquartered in the United States, it focuses on delivering meaningful genetic insights to improve health outcomes.
No recent news for this company.
No recent deals for this company.